Class differences in calcium-channel blockers in vasospastic angina

Circulation Journal

Volumn 74, Issue 9, 2010, Pages 1806-1807

  Baek, Sang Hong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BENIDIPINE; BENZODIAZEPINE DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIMIDINE DERIVATIVE; DILTIAZEM; NIFEDIPINE; PHENYLALKYLAMINE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG; VERAPAMIL;

ANGINA PECTORIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY SPASM; DRUG CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED MEDICINE; HEART MUSCLE ISCHEMIA; HUMAN; PROGNOSIS; SYMPTOM; THERAPY EFFECT; VASODILATATION;

CALCIUM CHANNEL BLOCKERS; CORONARY VASOSPASM; HUMANS; TREATMENT OUTCOME;

EID: 77956114003     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0711     Document Type: Editorial

References (12)

1. Shimokawa H, Nagasawa K, Irie T, Egashira S, Egashira K, Sagara T, et al. Clinical characteristics and long-term prognosis of patients with variant angina: A comparative study between western and Japanese populations. Int J Cardiol 1988; 18: 331-349.
2. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999; 33: 1442-1452.
3. Maseri A, Beltrame JF, Shimokawa H. Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. Circ J 2009; 73: 394-403.
4. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm: Clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 2008; 51: 2-17.
5. Kim PJ, Seung KB, Kim DB, Her SH, Shin DI, Jang SW, et al. Clinical and angiographic characteristics of acute myocardial infarction caused by vasospastic angina without organic coronary heart disease. Circ J 2007; 71: 1383-1386.
6. Cannon C, Braunwald E. Unstable angina and non-ST elevation myocardial infarction. In: Libby P, Bonow R, Mann D, Zips D, Braunwald E, editors. Braunwald's heart disease. 8th edn. Philadelphia: Saunders Elsevier, 2008; 1338-1339.
7. Chahine RA, Feldman RL, Giles TD, Nicod P, Raizner AE, Weiss RJ, et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina: Amlodipine Study 160 Group. J Am Coll Cardiol 1993; 21: 1365-1370.
8. Zanchetti A. Calcium channel blockers in hypertension. In: Black H, Elliott W, editors. Hypertension. Philadelphia: Saunders Elsevier, 2007; 268-270.
9. Nishigaki K, Inoue Y, Yamanouchi Y, Fukumoto Y, Yasuda S, Sueda S, et al. Prognostic effects of calcium channel blockers in patients with vasospastic angina: A meta-analysis. Circ J 2010; 74: 1943-1950.
10. Chang K, Baek SH, Seung KB, Kim PJ, Ihm SH, Chae JS, et al. The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm. Coron Artery Dis 2003; 14: 293-299.
11. Yamamoto E, Kataoka K, Dong Y, Nakamura T, Fukuda M, Nako H, et al. Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats. J Hypertens 2010; 28: 1321-1329.
12. Moriyama T, Karasawa A. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs. Biol Pharm Bull 1994; 17: 1468-1471.